MAZE peer analysis
Maze Therapeutics (MAZE) against its competitors: price, today's move, 1-year return and market value side by side.
MAZE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARDX Ardelyx | $2.85 | -4.68% | -46.88% | $827.02M |
| BIOA BioAge Labs | $5.37 | -3.01% | -26.10% | – |
| DMAC DiaMedica Therapeutics | $9.34 | 3.32% | 34.43% | $580.78M |
| IVA Inventiva | $3.83 | 5.51% | -9.93% | – |
| PTCT PTC Therapeutics | $65.39 | -0.43% | -3.10% | $5.76B |
| SEPN Septerna | $48.78 | 3.02% | 143.42% | – |
| TVTX Travere Therapeutics | $49.00 | 0.27% | 43.22% | – |
| MAZE Maze Therapeutics | $34.69 | 6.64% | 0.15% | – |
- MAZE's peers: ARDX (Ardelyx), BIOA (BioAge Labs), DMAC (DiaMedica Therapeutics), IVA (Inventiva), PTCT (PTC Therapeutics), SEPN (Septerna), TVTX (Travere Therapeutics).
Updated 2026-11-07 11:55 UTC